Acquired Cold-Induced Urticaria in Pediatric Patients: A 22-Year Experience in a Tertiary Care Center (1996-2017)

Christina S K Yee1, Kristel El Khoury1, Sultan Albuhairi1

  • 1Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.

Insights

Acquired cold-induced urticaria (ACU) in children can lead to severe anaphylaxis, especially during activities like swimming. A positive cold stimulation test (CST) significantly increases this risk, highlighting the need for caution and preparedness.

Area of Science:

  • Pediatric Allergy and Immunology
  • Dermatology
  • Clinical Immunology

Background:

  • Acquired cold-induced urticaria (ACU) is a rare condition that has been understudied in pediatric populations.
  • Understanding the presentation and potential severity of ACU in children is crucial for timely diagnosis and management.

Purpose of the Study:

  • To investigate the clinical presentation of acquired cold-induced urticaria in children.
  • To assess the risk of anaphylaxis associated with ACU in pediatric patients.
  • To identify factors that may predict severe reactions.

Main Methods:

  • A retrospective chart review was conducted on 415 children diagnosed with ACU between 1996 and 2017.
  • Data collected included patient demographics, atopic history, reaction severity, triggers, and cold stimulation test (CST) results.
  • Statistical analysis was used to determine associations between variables and anaphylaxis risk.

Main Results:

  • Of 415 pediatric ACU patients, 18.6% experienced anaphylaxis (grade 3 reactions), often triggered by swimming.
  • A positive CST result was significantly associated with an increased risk of anaphylaxis (11.7% even with negative CST).
  • Disease resolution was observed in 8.9% of patients, linked to a lack of prior anaphylaxis.

Conclusions:

  • This study, the largest on pediatric ACU, indicates a substantial risk of anaphylaxis, with nearly a fifth of patients experiencing severe reactions.
  • A positive CST is a key indicator for higher anaphylaxis risk in ACU.
  • Recommendations include prescribing epinephrine and educating families on managing ACU triggers and severe reaction risks.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Specialized Care Centers and Settings-I01:30

Specialized Care Centers and Settings-I

Specialized care settings or centers are situated in convenient locations within the community and offer care to a specific group or population. They consist of daycare facilities, mental health facilities, rural health facilities, educational institutions, industries, shelters for the homeless, and rehabilitation facilities.
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
1.4K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226